- Office of Management and Budget (OMB)
- Centers for Disease Control (CDC)
- Department of Energy (DOE)
- FDA
- NASA
- National Institutes of Health (NIH)
- National Science Foundation (NSF)
- HHS-OASH GAM - Office of the Assistant Secretary of Health, Grants Acquisition Management
- Administration for Children& Families (ACF)
- Agency for Healthcare Research and Quality (AHRQ)
- SAMHSA - Substance Abuse and Mental Health Services Administration (SAMHSA)
- DOD - Office of the Under Secretary of Defense for Research & Engineering, Basic Research-Research Directorate
- United States Army Medical Research Acquisition Activity (USAMRAA)
Office of Management and Budget (OMB)
- M-20-26 MEMORANDUM TO THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES Subject: Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations
- M-20-21 MEMORANDUM TO THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES Subject: Implementation Guidance for Supplemental Funding Provided in Response to Coronavirus Disease 2019 (COVID-19)
- M-20-20 MEMORANDUM TO THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES Subject: Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID-19)
- M-20-17:MEMORANDUM FOR THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES Subject: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations
- M-20-18: MEMORANDUM FOR THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES Subject: Managing Federal Contracts Performance Issues Associated with the Novel Coronavirus (COVID-19)
- M-20-11: MEMORANDUM FOR THE HEADS OF EXECUTIVE DEPARTMENTS AND AGENCIES Subject: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19)
Summary of Agency Implementation
Centers for Disease Control (CDC)
- Information for CDC Applicants and Recipients of CDC Funding
- Flexibilites Available to Applicants and Recipients of Federal Assitance Affected by COVID-19
- General Funding and Grants Frequently Asked Questions regarding COVID-19
- Interim Guidance for Administrators of US Institutions of Higher Education
Top
National Insitutes of Health (NIH)
- NOT-OD-21-026 Notice of Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
- NOT-OD-21-006 Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
- NOT-NS-21-004 Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career TGransition Award During the COVID-19 Pandemic
- NOT-HD-20-030 Notice of Change to the Eligibility of Principal Investigators in PAR-20-042: NCMRR Early Career Research Award (R03 Clinical Trial Optional)
- NOT-DE-20-031 Notice of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00)
- NOT-AI-20-068 Notice to Extend Eligibility for Submission of NIAID K99/R00 Pathway to Independence Award Applications (and Physician Scientist K99/R00) due to COVID-related Disruptions
- NOT-AI-20-054 NIAID Late Application Policy forNIAID-Specific FOAs with Due Dates in July and August 2020
- NOT-HG-20-042 Clarifying late Application Policy Receipt Dates for NHGRI-Specific FOAs with Application Due Dates in May, June, and July and Rescinding NOT-HG-20-041
- NOT-CA-20-072 NCI Late Application Policy for NCI-specific RFAs with Application Due Date of June 24, 2020
- NOT-AI-20-053 NIAID Late Application Policy for NIAID-specific RFAs with Due Dates in June 2020
- NOT-HG-20-041 NHGRI Late Appplication Policy for NHGRI-specific ROAs with Application Due Dates in May, June, and July
- NOT-CA-20-069 Late Application Policy for June 17, 2020 Application Due Date of PAR-19-242, Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Due to Public Health Emergency for US Coronavirus Disease 2019
- NOT-HD-20-016 NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)
- NOT-AG-20-033 NIA Lae Application Policy for NIA-Specific FOAs with Application Due Dates in May, June, and July 2020
- NOT-CA-20-068 Late Application Policy for May 25, 2020, Application Due Date of NCI's Cancer Research Education Grants Program (R25) Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 Due to Public Health Emergency for US Coronavirus Disease 2019
- NOT-AI-20-048 NIAID Late Application Policy for Funding Opportunities RFA-AI-20-001 and RFA-AI-20-009
- NOT-GM-20-029 NIGMS Late Application Policy for NIGMS-Specific FOAs with Application Due Dates in May 2020
- NOT-OD-20-105 NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)
- NIH Extramural Response to Natural Disaster and Other Emergencies
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients
- NOT-OD-20-083: General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
- NOT-OD-20-082: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- NOT-OD-20-086: Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
- NOT-OD-20-087: Guidance for NIH-funded Clinical Trials and Human Subjects Affected by COVID-19
- Special OLAW Webinar on March 19: Pandemic Contingency Planning on its Impact on Animal Care
- NIH Message to Applicants and Recipients of NH Funds on Flexibilities Needed for COVID-19 (YouTube video)
- NOT-OD-20-088: Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
- NOT-OD-20-091: UPDATE: NIH Late Applicatio Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- NIH NCI - Interim Guidance for Patients on Clinical Trials Supported by the NCI Cancer Therapy Evaluation Programs and the NCI Community Oncology Research Program (NCORP)
Summary of Agency Implementation
Top
Agency for Healthcare Research and Quality (AHRQ )
- NOT-HS-21-002 AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
- NOT-HS-20-010
Summary of Agency Implementation
Top
United States Army Medical Research Acquisition Activity (USAMRAA)
Summary of Agency Implementation
Top